Oral Testosterone Undecanoate

DRUG7 trials

Sponsors

Clarus Therapeutics, Inc., San Diego Sexual Medicine

Conditions

Hypoactive Sexual Desire DisorderHypogonadismMale Hypogonadism

Phase 1

Phlebotomy Study of Testosterone Undecanoate

CompletedNCT02670343

Clarus Therapeutics, Inc.Hypogonadism

Start: 2016-01-31End: 2016-03-31Updated: 2018-03-09

Phase 2

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

CompletedNCT02921386

Clarus Therapeutics, Inc.Hypogonadism

Start: 2016-10-31End: 2017-01-21Updated: 2018-05-17

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

Not yet recruitingNCT06082817

San Diego Sexual MedicineHypoactive Sexual Desire Disorder

Start: 2025-01-01End: 2025-12-31Target: 30Updated: 2024-11-13

Phase 3

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

CompletedNCT01403116

Clarus Therapeutics, Inc.Male Hypogonadism

Start: 2011-07-31End: 2013-09-30Updated: 2018-08-14

Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men

CompletedNCT01699178

Clarus Therapeutics, Inc.Male Hypogonadism

Start: 2012-08-31End: 2014-04-30Updated: 2021-06-28

Safety and Efficacy Trial of Testosterone Undecanoate

CompletedNCT01765179

Clarus Therapeutics, Inc.Male Hypogonadism

Start: 2013-01-31End: 2013-07-31Updated: 2017-12-12

A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

CompletedNCT02722278

Clarus Therapeutics, Inc.Hypogonadism

Start: 2016-03-31End: 2016-11-30Updated: 2018-02-23